Latest tumor Stories
LONDON, May 19, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
About one in seven men will develop prostate cancer over the course of a lifetime, and about one in 36 men will die from it.
Harvard Stem Cell Institute scientists at Massachusetts General Hospital have a potential solution for how to more effectively kill tumor cells using cancer-killing viruses.
DUBLIN, May 16, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/6mvft5/circulating_tumor)
30mg/m2 dose cohort had been completed; enrollment of 40mg/m2 cohort has been initiated VANCOUVER, British Columbia and MENLO PARK, Calif., May 16, 2014 /PRNewswire/ --
First Case Study Announced While Broader Data Being Collected; Evidence Indicates Substantial Tumor Necrosis and Initial Tumor Regression BETHESDA, Md., May 15, 2014 /PRNewswire/ --
Comprehensive Molecular Profiling Provides Oncologists Treating Patients with Rare, Aggressive or Refractory Cancers with Better Understanding of How to Treat Cancer IRVING, Texas, May 15,
WHIPPANY, N.J., May 14, 2014 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc.
SAN DIEGO, May 14, 2014 /PRNewswire/ -- Aethlon Medical, Inc. (OTCQB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce.
MIT researchers have devised a novel cancer treatment that destroys tumor cells by first disarming their defenses, then hitting them with a lethal dose of DNA damage.
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.